Oncoheroes signs cancer asset licensing deal with Boehringer
US-based biotech company Oncoheroes Biosciences has entered into a licensing agreement with Boehringer Ingelheim for...
Read More...
Focus:
Germany
-
![Boehringer Lupin agreement]()
Boehringer licences Lupin’s cancer asset in $720m deal
Germany-based Boehringer Ingelheim has entered into a licensing, development and commercialisation agreement worth more than...
Read More...
-
![Sandoz licences proposed natalizumab biosimilar]()
Sandoz licences proposed multiple sclerosis biosimilar from Polpharma
Novartis unit Sandoz has signed an agreement with biopharmaceutical firm Polpharma Biologics for exclusive rights...
Read More...
-
![Bayer to divest Animal Health unit for $7.6bn]()
Bayer to divest Animal Health unit for $7.6bn
Bayer has signed a definitive agreement to sell its Animal Health unit to US-based Elanco...
Read More...
-
![CureVac, Yale University to develop mRNA-based lung therapies]()
CureVac and Yale University to develop mRNA-based lung therapies
Biopharmaceutical firm CureVac has signed a collaborative research agreement with US-based Yale University to discover...
Read More...
-
![Boehringer partners MD Anderson on virtual R&D center]()
Boehringer partners with MD Anderson on virtual R&D centre
Boehringer Ingelheim has collaborated with The University of Texas MD Anderson Cancer Center to create...
Read More...
-
![Sensyne Health and Bayer partner on AI drug development]()
Sensyne Health and Bayer partner on AI drug development
Sensyne Health, a UK-based clinical artificial intelligence (AI) technology firm, has collaborated with German pharmaceutical...
Read More...
-
ACG Engineering acquires Germany’s Xertecs
ACG Group unit ACG Engineering (ACGE) has purchased 100% shares of German pharmaceutical processing equipment...
Read More...
-
![Boehringer forms alliance with Bridge Biotherapeutics for IPF drug]()
Boehringer forms alliance with Bridge Biotherapeutics for IPF drug
Boehringer Ingelheim has entered a collaboration and licence agreement to develop South Korea-based Bridge Biotherapeutics’...
Read More...
-
![Gotham Mercachem epitransciprtomic]()
Gotham and Mercachem generate epitranscriptomic target library
New York-based RNA-focused drug discovery company Gotham Therapeutics and German contract research organization (CRO) Mercachem...
Read More...
Close
Close
Close
Go Top
